Biomarkers in the detection
of Colon and Rectal Cancer
Gina Wallar, MPH
Colorectal CRC
2009 Stats (US)
Risk Factors
Biomarkers
Current Screening Guidelines
Transferrin
Colorectal Cancer (CRC)
Picture in the U.S.
3rd most common cancer in men and
women
2nd major cancer killer
Detectable
Treatable
Screening- Compliance a major factor
2009 CRC Statistics
106,100 cases of colon cancer expected
40,870 cases of rectal cancer expected
• Accounts for 9% of all cancer deaths
• 5-year survival rate for Stage I is 90%
• 5-year survival rate for Stage IV is 11%
Less than half of colon cancer cases are
detected when the cancer is localized
Colon Cancer-Risk Factors
Family History/Genetics
Age
History of colon cancer, polyps, bowel disease
Race/Ethnicity
Alcohol
Smoking
Diet
Sedentary Lifestyle
Obesity
Diabetes
Smoking (Incidence versus Mortality)
Alcohol and Colon Cancer
Alcohol and Rectal Cancer
Colon Cancer and Diet
“Western Civilization”
High in Animal Fat-Bile acid production
Low Fiber
Refined sugar-Hyperinsulinaemia
Low Vegetable Intake
No longer considered a main contributor to
CRC
Red Meat Consumption
CRC and Fish Consumption
Geelen, A. et al. Am. J. Epidemiol. 2007 0:kwm197v1-197; doi:10.1093/aje/kwm197
Green Tea
Colon Cancer and Physical Activity
Sedentary lifestyle is positively associated
with colon cancer (Giovannucci)
Physical activity- obesity connection
Sex steroid hormone levels change with
physical activity initiation
Estradiol decreases
SHBG increases
Testosterone increases
Obesity and Colon Cancer
Obesity and Rectal Cancer
Colon Cancer and Obesity
Increase in adipose tissue
Increase in insulin
Association stronger in men and premenopausal
women
Gender as an effect modifier on the obesity
colon cancer association suggest that sex
steroid hormones play a role though the
mechanism is not well understood
Biomarkers of Obesity
With Obesity
Decreased SHBG
Decreased total T (men)
Increased free and total E
Does obesity drive these changes in
hormones or do hormones drive changes
in body shape, weight, and adiposity?
Mechanism
Hypothalamus/GnRH
Adipose tissue
Adrenal Secretion
Pituitary
LH/FSH
Ovary
Androstenedione
Testis
Cholesterol pathway
Liver
Testosterone
lo SHBG
Estrogens
Androgens
Hyperthyroidism Glucocorticoids
Hypothyroidism
Anorexia
Pregnancy
Obesity
Insulin/IGF-1
PCOS
Diabetes
Free T
+
Aromatase
Androgens
Bound T
SHBG
hi SHBG
Age, Obesity
Estradiol
Free E
+
Bound E
Estrogens
Adipose Tissue
Features
Established relationship
with insulin resistance
Play a role in the
regulation of insulin
signaling and action
Source of inflammation
Adipocytokines
Leptin
Adiponectin
IL-6
TNFalpha
FFA
Resistin
Diabetes and Colon Cancer
Similarity of lifestyle/environmental risk
factors
Positively associated
Hyperinsulinaemia initiates carcinogenesis
Insulin is a growth factor for colonic
epithelial cells and can reduce apoptosis
Insulin is a mitogen of tumor cells in vitro
Diabetes and Colon Cancer
Mechanism
Adiposity
Varying levels of
Adipocytokines
Insulin
Resistance
IGF-1 Increases
Insulin Increases
Cell
Proliferation
Increases
Apoptosis
Decreases
Activates IR
Tumor Development
Activates
IGFR
Growth Hormones
Insulin increases IGF-1
IGF-1 activates the IGF receptor
Decreases apoptosis
Increases cell proliferation
Physicians Health Study reported RR of
2.51 for those in the high IGF-1 quintile
Current CRC Screening
Goal: Reduce mortality via a reduction in
incidence of advanced disease
1-Stool-based tests (Occult Blood and DNA)
2-Structural exams (Colonscopy (CSPY),
Flexible Sigmoidoscopy (FSIG), DoubleContrast Barium Enema (DCBE), and
Computed Tomographic Colongraphy
(CTC))
Current Recommendations for
Average-Risk Individuals aged >50
Detection of adenomatous polyps and
cancer:
Every 5 years (1 of the following): FSIG,
DCBE, CTC
or Every 10 years: CSPY
Detection of cancer:
Annual Stool Blood Test
sDNA Test (Interval unknown)
Biomarkers
APC (~70%)
p53 (~50%-70%)
K-ras (~50%)
IGF-1 and CEA
MSI
Stool DNA
Stool DNA, tissue
Stool and colonic DNA
Serum
Tissue, Stool and
Plasma DNA
Other various biomarkers in tissue: Src, SMAd4, SMAD2,
DCC, hMSH2, hMLH1, hPMS1, hPHMS2, hMSH6, Ploidy
Biomarkers
Srivastava et al Biomarkers for Early Detection of Colon Cancer
Meta-Analysis of GWAS
Transferrin
77KD, β-globulin
Main Function: Transport extracellular iron
into cells through membrane receptormediated endocytosis
More stable than hemoglobin
Required for cell growth and survival
Increased Tf level in serum and body fluid
in several cancer types
Transferrin Dipstick
Disease
N
IFOBT Tf
Tf +
IFOBT
+ -
+ -
+ -
Colorectal Cancer
40
30
(75)
10
(25)
32
(80)
8
(20)
36
(90)
4
(10)
Premalignant
36
16
(44)
20
(56)
26
(72)
10
(28)
28
(78)
8
(22)
Low risk
34
4
(12)
30
(88)
8
(24)
26
(76)
10
(29)
24
(71)
Rao et al Transferrin Dipstick as a Potential Novel Test for Colon Cancer Screening
Summary
Much research has been conducted on
risk factors and biomarkers for CRC
Room for improvement in early detection
New types of biomarkers
New dipsticks/combinations with better
performance to potentially increase
compliance
Thank You